
Diagnostic test could help doctors refine prostate cancer treatment
A new genomic test called Decipher could help doctors decide which prostate cancer patients actually need more aggressive treatment, potentially sparing others harsh side effects.
Prostate cancer is the most common cancer in men—in 2013, it affected more than 1 million men across the world. The cancer does not behave the same way in every patient, and doctors have long faced a difficult balancing act between identifying patients who will benefit from more intensive treatment and those who may do just as well without it. Treating someone more aggressively than necessary is associated with increased side effects and poorer quality of life.
Researchers from University College London presented findings showing a genomic test could personalise prostate cancer treatment decisions at a major cancer conference in Madrid.
The Decipher test was analysed across data from over 27,000 men, and every 0.1 increase in score raised the risk of distant cancer spread with a hazard ratio of 1.49, the study found.
Men with high-risk prostate cancer but a low Decipher score could potentially be spared more intensive treatment and its side effects, the lead researcher said.
The Decipher test predicted which men with high-risk, node-negative prostate cancer would benefit from adding abiraterone, so it may be worth asking an oncologist about genomic testing options.
Five minutes for you
More from Cuppa
Pauline Parker, killer in Heavenly Creatures case, dies aged 88Pauline Parker, who murdered her mother in Christchurch in 1954 in the case that inspired Peter Jackson's Heavenly Creatures, has died in Scotland aged 88.
Breast cancer survivors face unique challenges treating menopause symptomsBreast cancer survivors managing menopause symptoms face extra complications around hormone therapy, but doctors say non-hormonal options and pelvic floor therapy can help.
‘Never seen this before’: $860k ATO audit leaves accountant baffledA Darwin tradie was hit with an $860,000 ATO bill, with up to $280,000 of that made up of penalties and interest after a bookkeeping error wiped out all his business expenses.
Former coach says Collingwood's woeful season is not the 'standard of AFLW that we expect to see'Collingwood's AFLW season hit a new low after failing to kick a single goal against Port Adelaide, with a former coach publicly criticising the team's defensive tactics.
Embattled Greens senator Jordon Steele-John confirms leave from parliament after allegations against him made publicGreens senator Jordon Steele-John has confirmed he will take leave from parliament while an independent investigation into allegations of misconduct towards women is completed.
High-Nicotine Vapes Tied to Greater Nicotine Dependence in Young AdultsA US study found young adults who use high-nicotine vapes are becoming as dependent on nicotine as cigarette smokers, and are 31 per cent less likely to quit.
Glioblastoma breakthrough reveals how brain cancer cells become more aggressiveScientists found that the thick fluid surrounding glioblastoma brain tumours can make cancer cells smaller and more invasive, potentially explaining why the cancer spreads so aggressively.
John will not attend parliament next weekWA Greens senator Jordon Steele-John says he will not attend parliament next week after a letter alleging serious misconduct against him was made public.




What readers are saying